statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.052
SG - Singapore	199
CN - Cina	105
IT - Italia	90
SE - Svezia	74
GB - Regno Unito	72
HK - Hong Kong	57
BR - Brasile	50
DE - Germania	49
FI - Finlandia	35
RU - Federazione Russa	30
VN - Vietnam	30
FR - Francia	17
ID - Indonesia	12
CA - Canada	10
BG - Bulgaria	9
KR - Corea	9
NL - Olanda	9
SI - Slovenia	8
IN - India	7
JP - Giappone	7
AR - Argentina	6
PL - Polonia	6
AT - Austria	4
IE - Irlanda	4
LT - Lituania	4
MX - Messico	4
BD - Bangladesh	3
IR - Iran	3
MY - Malesia	3
TR - Turchia	3
AZ - Azerbaigian	2
CL - Cile	2
CO - Colombia	2
ES - Italia	2
HR - Croazia	2
JO - Giordania	2
LU - Lussemburgo	2
MC - Monaco	2
SK - Slovacchia (Repubblica Slovacca)	2
ZA - Sudafrica	2
BE - Belgio	1
BO - Bolivia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
IQ - Iraq	1
KE - Kenya	1
KH - Cambogia	1
NP - Nepal	1
RO - Romania	1
SA - Arabia Saudita	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.004

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	338
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies	282
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients	225
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	222
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort	222
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering	211
Evaluation of HIV transmission clusters among natives and foreigners living in Italy	194
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016	184
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus	148
Totale	2.026

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	134	0	0	0	0	0	0	15	38	20	14	30	17
2021/2022	238	31	16	15	11	14	16	12	15	24	14	47	23
2022/2023	283	37	41	21	30	30	28	15	22	26	0	17	16
2023/2024	137	6	8	14	16	28	14	11	15	2	1	7	15
2024/2025	466	15	5	6	39	77	72	41	21	49	23	45	73
2025/2026	491	64	32	50	94	177	69	5	0	0	0	0	0
Totale													2.026